Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03241589 · ClinicalTrials.gov registry record
Teledermatology Mobile App: Patient Facing
A clinical trial, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- 466
- Enrollment target
NCT03241589: Completed study, sponsored by VA Office of Research and Development.
NCT03241589 is a clinical trial that has completed, run by VA Office of Research and Development. The registered enrollment target is 466 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03241589 has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- 466 participants
- Enrollment target
Study Summary
This study was designed to measure the impact of two teledermatology apps to provide direct to patient teledermatology follow up care, Patient Viewer and My VA Images, with a trial on access to dermatology care. The overall hypothesis was that sites implementing Department of Veterans Affairs' (VA) teledermatology mobile apps would significantly augment the use of teledermatology and improve Veterans' access to skin care relative to control sites. Specifically, the investigators hypothesized that these apps would improve established patients' ability to follow-up with dermatology care remotely, reducing patient travel to dermatology clinics while opening up dermatology clinic space for other patients. Due to a lack of participation by sites during the study which was conducted during the novel coronavirus (COVID-19) pandemic, the groups examined are Veterans who live in rural areas compared to those in urban areas. Previously the study included a parallel trial to evaluate another teledermatology mobile app, VA Telederm. This trial was no longer feasible within this study's funding timeline due to limitations imposed on the mobile app by Office of Information \& Technology that were not under the control of the PI or the operational partner, Office of Connected Care (OCC).
Primary Outcome
Whether patient had a successful completion of a remote follow-up visit during the study period, which included 1 year and 4 months. The time frame of the follow up varied as clinically appropriate.
Interventions
- OTHER Direct to patient facing mobile apps introduction
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 466 participants |
| Start Date | 2019-05-13 |
| Est. Completion | 2020-12-31 |
What the finished NCT03241589 record still lists
NCT03241589 is an observational study that tracks outcomes without assigning an intervention. The registered 466 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Direct to patient facing mobile apps introduction is the first listed.
NCT03241589 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03241589 about?
NCT03241589 is a clinical study titled "Teledermatology Mobile App: Patient Facing". This study was designed to measure the impact of two teledermatology apps to provide direct to patient teledermatology follow up care, Patient Viewer and My VA Images, with a trial on access to dermatology care. The overall hypothesis was that sites implementing Department of Veterans Affairs' (VA) ...
What is the current status of trial NCT03241589?
This trial is currently completed. The enrollment target is 466 participants. The study started on 2019-05-13. Estimated completion is 2020-12-31.
What interventions are being tested in trial NCT03241589?
The interventions under investigation include: Direct to patient facing mobile apps introduction (OTHER).
Who is sponsoring clinical trial NCT03241589?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05312879 · 466 participants · Phase 2
Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1- Mediated Proteinuric Kidney Disease
- NCT06917404 · 466 participants · Phase 3
A Study to Investigate the Treatment Effect of Subcutaneous Injections of Pentosan Polysulfate Sodium Compared With Placebo in Adult Participants With Knee Osteoarthritis Pain.
- NCT07055165 · 466 participants · NA
Connect2Care: Prostate Cancer Education and Screenings for African American Men
- NCT07214779 · 466 participants · Phase 3
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI